Chapter 18: Licence Renewal, Changes and Transfer Management
Hello, everyone. I am Drew Tang from RGYS. In the previous chapters, RGYS may assist with document preparation and project coordination within the written scope of services; personnel qualifications, statutory roles and professional judgments are to be verified and assumed by the respective responsible parties, and approval is decided independently by the competent authority. However, obtaining a licence is only the beginning of compliant operations. Over the long term, you will inevitably encounter matters such as licence renewal, changes to information and even adjustments to your corporate structure. These subsequent management tasks are equally crucial: any oversight may interrupt your business or even expose you to legal risks. In this chapter, drawing on project documentation and current supporting authorities, I will analyse in depth the key points and practical procedures for licence renewal, changes and transfers, helping you achieve lasting business stability.
1. Licence renewal management: ensuring ongoing compliance
Licences relating to pharmaceutical products are not valid indefinitely and must be renewed periodically with the Drug Office, Department of Health or the Chinese Medicine Regulatory Office. Renewal may seem routine, but you need to manage the timing, documentation requirements and review points precisely. A successful renewal application is the best evidence of your company’s ability to maintain ongoing compliance.
Under the Pharmacy and Poisons Regulations (Cap. 138A), most licences are valid for one year. Licence holders must submit renewal applications in the prescribed manner within the specified period before the licence expires. I generally advise clients to start preparing for renewal at least three months in advance. This allows sufficient time to prepare documents and deal with unexpected issues, such as requests for additional information or clarification. A late application will cause the licence to lapse. You must then stop all relevant licensed activities and apply for a new licence, which will involve considerable time and expense.
Drew Tang's tip: Be sure to set a prominent reminder in your company calendar, such as starting the renewal process 4 months before the licence expires. For companies managing multiple licences, a Licence Ledger is a highly effective tool for clearly tracking each licence's expiry date, renewal status and key person responsible.
The core documents usually required for a renewal application include a completed renewal application form, a copy of the latest Business Registration Certificate, the company’s Annual Return (if applicable), and a cheque for the relevant fees. Note that if your company has undergone any significant changes during the past year, such as replacing the Authorised Person or Responsible Person, you must submit the relevant supporting documents with the renewal application and ensure that the Drug Office has approved these changes in advance. Any unapproved change may obstruct the renewal application.
2. Licence change management: responding to business developments
As a business develops, its organisational structure, premises and business scope may change. When such changes affect key information stated on the licence, you must proactively notify the regulator and obtain approval. Unauthorised changes not only breach licence conditions but may also give rise to serious compliance risks.
Common licence changes include changes to the business premises, key personnel (such as the Person-in-Charge or pharmacist), and additions to or reductions in the scope of business. For example, if you plan to relocate your warehouse or there is a change of company directors or shareholders, the change must be notified. A change in the company’s shareholding structure may appear to be an internal company matter, but regulatory authorities pay close attention to whether a change in ultimate control could affect the company’s ability to operate compliantly. In my experience, any change involving more than 30% of the shares should be discussed proactively with the Drug Office to explain the situation and avoid an adverse impact on licence status.
📘 Regulatory basis: The Pharmacy and Poisons Ordinance (Cap. 138) expressly provides that a licence holder must operate at the premises specified on the licence and comply with all conditions imposed by the Board. Any changes to these conditions must be approved in advance. This means that “act first and seek approval later” is absolutely not an option in licence management.
To help you understand more clearly the documents and procedures required for different types of change, I have prepared the table below for your reference. Please note that this is general guidance only; specific requirements may vary from case to case.
| Type of change | Key requirements and documents needed | Estimated approval period |
|---|---|---|
| Change of premises (relocation) | The new premises must also comply with the requirements of the Good Practices Guide for Manufacturers of Pharmaceutical Products (GMP) or the Guide to Good Distribution Practice for Pharmaceutical Products (GDP). Plans for the new premises, a tenancy agreement and fire safety certification must be submitted, and the premises are subject to an on-site inspection. | 8–12 weeks |
| Change of Person-in-Charge / Authorised Person | New personnel must have suitable professional qualifications and experience. You must submit their identity documents, academic and professional qualification certificates, detailed CVs and declarations of no criminal record. | 4–6 weeks |
| Change of company name | Submit the Certificate of Change of Name issued by the Companies Registry and the updated Business Registration Certificate. | 2–3 weeks |
| Change of company shareholding / directors | Submit the latest Annual Return (NAR1), Notice of Change of Directors (ND2A) and other documents. If there is a change in major control, it is advisable to include an explanatory letter describing the impact of the change on the company’s operational compliance. | 4–8 weeks |
III. Legal restrictions and points to note concerning licence transfers
During business discussions, I am often asked: “Drew Tang (Tang Shangyong), my friend’s company has a pharmaceutical licence. Can it be transferred directly to us?” This is a very common misconception. Under Hong Kong’s legal framework, licences relating to either Western medicines or Chinese medicines are themselves not directly transferable (Non-transferable). A licence is a specific permission granted by the regulator following a rigorous assessment of a particular applicant entity, including its personnel, premises and Quality Management System.
This means that you cannot transfer a licence from Company A directly to Company B as if it were an ordinary asset being bought and sold. The law does not allow this because Company B has not undergone the same stringent assessment process as Company A. Any attempt to “transfer” a licence by agreement is invalid and unlawful. If discovered, the licence concerned may be revoked immediately and legal liability may also follow.
📕 Risk warning: Do not trust any channel claiming to be able to “buy or sell” or “transfer” a Hong Kong pharmaceutical licence. Such conduct seriously contravenes the Pharmacy and Poisons Ordinance and the Chinese Medicine Ordinance. It may cause both parties to the transaction substantial financial losses and could also result in criminal prosecution.
So, if you genuinely wish to acquire a licensed business, how should you proceed? The only compliant route is to acquire 100% of the shares in the company that holds the licence. Under this arrangement, the licence itself is not transferred; it remains with the original corporate entity. What changes are the company’s shareholders and directors. After completion, the new shareholders must promptly notify the Drug Office or the Chinese Medicine Regulatory Office of changes to directors and persons in charge, following the “licence change” procedure described in the previous section. The regulatory authority will reassess the qualifications and capabilities of the new management team to ensure that the company can continue to operate compliantly under the new ownership. This is a rigorous and complex legal and compliance process. I strongly recommend engaging a professional consultant such as Rengangyongsheng to provide end-to-end guidance on due diligence, transaction structuring and change applications, helping to ensure a smooth and compliant transaction.